Transitional cell carcinoma (morphologic abnormality)
POUT-T
Year Started: 2014
A translational substudy of a phase III randomised trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer
- Access:
- Open only through collaboration
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
-
Commercial restriction, Other animal work restriction, Outside EU access restriction, Xenograft restriction
Associated Data Type |
Procurement Timeframe |
Biomarker datasets |
> 6 months |
Clinical records |
> 6 months |
Followup records |
> 6 months |
Freezer temperature logs |
0 - 3 months |
Genomic datasets |
> 6 months |
Pathology records |
> 6 months |
Treatment records |
> 6 months |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |
Urine |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |
Urine |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Male
Young adult (18 - 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |
Urine |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
75% -99% |